| NCT Number | NCT05304728 |
| Lead Sponsor | Beckman Coulter, Inc.
Collaborators: Biomedical Advanced Research and Development Authority |
| Conditions | Severe Sepsis, Severe Sepsis Without Septic Shock |
| Enrollment | 40,000 participants |
| Start Date | 2021-02-15 |
| Primary Completion | 2025-03-30 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2024-06-21 |